dMMR
Jemperli Approval Expanded to Treatment of dMMR Solid Tumors
The FDA granted accelerated approval to the programmed cell death receptor-1 agent dostarlimab-gxly (Jemperli, ...
AUGUST 19, 2021
DNA Mismatch Repair Genes Linked to Prognosis in CRC Patients
Deficient DNA mismatch repair genes (dMMR) can serve as a biomarker to determine the prognosis in stage II and III ...
OCTOBER 16, 2016
Load more